Table 1.
Observation group (n=51) | Control group (n=50) | t | P | |
---|---|---|---|---|
Gender | 0.562 | 0.757 | ||
Male | 36 | 35 | ||
Female | 15 | 15 | ||
Age | 55.6±6.9 | 52.68±7.6 | 2.697 | 0.102 |
Disease course | 5.1±3.2 | 5.3±3.3 | 2.984 | 0.095 |
Painful area | 0.756 | 0.651 | ||
Hips | 51 | 50 | ||
Groin | 51 | 50 | ||
Knee | 12 | 11 | ||
FICAT staging | 3.316 | 0.069 | ||
Phase I | 36 | 34 | ||
Phase II | 15 | 17 | ||
Smoking | 36 | 35 | 1.983 | 0.983 |
Drinking | 15 | 16 | 2.695 | 0.058 |
Diabetes | 23 | 24 | 0.022 | 0.997 |
Hypertension | 19 | 20 | 0.247 | 0.619 |
Coronary heart disease | 13 | 16 | 0.342 | 0.066 |
Chronic kidney disease | 9 | 6 | 2.206 | 0.137 |
Chronic obstructive pulmonary disease | 7 | 7 | 0.381 | 0.537 |
Anemia | 6 | 4 | 0.628 | 0.428 |
Note: FICAT: Ficat and Arlet classification.